Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy (TripleEX)

NCT04638920 is registered in ClinicalTrials.gov with Malcolm Kohler as lead sponsor.

NCT NCT04638920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04638920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy (TripleEX)
Lead sponsor
Malcolm Kohler
Phase
Observational
Overall status
Completed
Start date
November 16, 2020
Completion date
April 30, 2024
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation